BBC · Virtus Biotech Clinical Trials ETF
United States · RS rating 27 · As of 2026-10-14
| Price | 40.15 USD |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 27 / 13 / 20 / 86 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 32 / 19 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +28.3% |
| Market cap (USD) | – |